Position in EOLS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$129,365
-$1,370,885 QoQ
Shares Held
31,476
-86.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,485,768 across 61 Drug Manufacturers - Specialty & Generic names. EOLS ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in EOLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $129,365 | 31,476 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,500,250 | 225,602 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,740,348 | 446,311 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $6,377,794 | 692,486 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $8,756,527 | 727,891 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,525,163 | 138,149 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,752,799 | 169,926 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $2,321,398 | 213,954 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $3,467,184 | 247,656 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $405,119 | 38,473 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,196,425 | 130,900 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $248,408 | 34,169 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $252,090 | 29,798 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $829,597 | 110,466 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $188,232 | 23,383 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $249,666 | 21,523 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $250,340 | 22,312 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $111,405 | 17,113 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $93,070 | 12,214 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $158,200 | 12,506 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $260,214 | 20,032 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $212,129 | 63,134 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $31,877 | 8,153 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $39,086 | 7,375 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $24,696 | 5,951 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||